logo-loader
AIM:HCM NASDAQ:HCM HKG:0013

Hutchmed (China) Ltd

Receive alerts
Market:
AIM
Price
265.05 GBX
Day Change
0.21%
Market Cap:
£2.28 b
52 weeks high
338.00
52 weeks low
173.60

In brief

Hutchmed (China) Ltd is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery, global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.

A dedicated organization of over 1,400 personnel has advanced eleven cancer drug candidates from in-house discovery into clinical studies around the world, with its first three oncology drugs now approved